09.20.12
NattoPharma ASA, Oslo, Norway, has announced that the United States Patent and Trade Office has approved and issued its patent application #09/850,804 (“ex-Unilver”) re. “Vitamin K2 Containing Food product.” According to Dr. Hogne Vik, CEO of NattoPharma, this new patent will strengthen NattoPharma's IPR and commercial platform in the U.S.. The patent will give NattoPharma a broad coverage on the use of menaquinones (vitamin K2) in the preparation of food products for promoting cardiovascular health.